(Q44264765)

1 December 2017

title

Electrophysiologic actions of dl-sotalol in patients with persistent atrial fibrillation (English)

1 reference

1 December 2017

0 references

Hung-Fat Tse

1

1 reference

1 December 2017

Chu-Pak Lau

series ordinal

2

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

Journal of the American College of Cardiology

1 December 2017

published in

1 reference

1 December 2017

volume

40

1 reference

1 December 2017

issue

12

1 reference

1 December 2017

page(s)

2150-2155

1 reference

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Heterogeneous changes in electrophysiologic properties in the paroxysmal and chronically fibrillating human atrium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Changes in atrial electrical properties following cardioversion of chronic atrial fibrillation: relation with recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Electrophysiological characteristics of the human atria after cardioversion of persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Recurrence of atrial fibrillation and the need for new definitions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Class III antiarrhythmic drug action in experimental atrial fibrillation. Differences in reverse use dependence and effectiveness between d-sotalol and the new antiarrhythmic drug ambasilide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Cycle length dependence of human action potential duration in vivo. Effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady-state frequencies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Effect of atrial fibrillation on atrial refractoriness in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

The class III antiarrhythmic drugs dofetilide and sotalol prevent AF induction by atrial premature complexes at doses that fail to terminate AF.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Insights into mechanisms of antiarrhythmic drug action from experimental models of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Contrasting efficacy of dofetilide in differing experimental models of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Electropharmacologic effects of pilsicainide, a pure sodium channel blocker, on the remodeled atrium subjected to chronic rapid pacing

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Effects of ionic remodeling on cardiac antiarrhythmic drug actions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Atrial fibrillation in the goat induces changes in monophasic action potential and mRNA expression of ion channels involved in repolarization

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Changes in the mRNA levels of delayed rectifier potassium channels in human atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902592-5

7 January 2021

10.1016/S0735-1097(02)02592-5

Identifiers

DOI

1 reference

1 December 2017

1 reference